TNXP - Tonix Pharmaceuticals Holding Corp
IEX Last Trade
0.2335
-0.022 -9.507%
Share volume: 15,934,682
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.26
-0.02
-8.68%
Summary score
24%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-39.54%
Return on assets
-31.18%
Return on sales
0%
Return on invested capital
374.36%
Total debt ratio
11.88%
Debt ratio change over timeo
-0.97%
Current Ratio
10.43%
Quick Ratio
0%
Cash Position Ratio
9.37%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-63.37%
Return on assets
-42.53%
Return on sales
0%
Return on invested capital
376.01%
Total debt ratio
17.78%
Debt ratio change over timeo
-0.96%
Current Ratio
8.12%
Quick Ratio
0%
Cash Position Ratio
7.43%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-26.47%
Return on assets
-24.32%
Return on sales
0%
Return on invested capital
358.06%
Total debt ratio
8.18%
Debt ratio change over time
-0.98%
Current Ratio
12.32%
Quick Ratio
0%
Cash Position Ratio
11.76%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-110.8%
Return on assets
-108.51%
Return on sales
0%
Return on invested capital
4.43%
Total debt ratio
-96.77%
Debt ratio change over time
-0.97%
Current Ratio
1.99%
Quick Ratio
0%
Cash Position Ratio
1.78%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TNXP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -39.54% | -3.05% | 11.55% | 6.27% |
| Return on assets | -31.18% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 374.36% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 36% | 67% | 59% |
| Total debt ratio | 11.88% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.97% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 8.12% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 7.43% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 16% | 35% | 35% |
| Short-term ratios | TNXP | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -63.37% | -25.62% | 17.94% | 7.14% |
| Return on assets | -42.53% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 376.01% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 17.78% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.96% | -23.44% | 9.66% | 0.6% |
| Dept financing | 4% | 25% | 45% | 8% |
| Current Ratio | 8.12% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 7.43% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 29% | 24% | 41% |